Orion Oyj
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
ORION CORPORATION
STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS
17 FEBRUARY 2025 at 15.15 EET
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds increased on 14 February 2025 above five (5) per cent of Orion Corporation’s total shares.
Total positions of BlackRock, Inc. and its funds subject to notification:
% of shares and voting rights (total of point A) | % of shares and voting rights through financial instruments (total of point B) | Total of both in % (points A + B) | Total number of shares and voting rights of issuer | |
Resulting situation on the date on which threshold was crossed or reached | 4.99% shares Below 5% voting rights | 0.03% shares Below 5% voting rights | 5.02% shares Below 5% voting rights | 141,134,278 shares 763,427,275 voting rights |
Position of previous notification (if applicable) | Below 5% shares Below 5% voting rights | Below 5% shares Below 5% voting rights | Below 5% shares Below 5% voting rights |
Notified details of the resulting situation on the date on which the threshold was crossed:
Point A: Shares and voting rights:
Class/type of shares ISIN code | Number of shares and voting rights | % of shares and voting rights | ||
Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | Direct (SMA 9:5) | Indirect (SMA 9:6 and 9:7) | |
FI0009014377 | 7,046,105 shares Below 5% voting rights | 4.99% shares Below 5% voting rights | ||
POINT A SUBTOTAL | 7,046,105 shares Below 5% voting rights | 4.99% shares Below 5% voting rights |
Point B: Financial instruments according to SMA 9:6a:
Type of financial instrument | Expiration date | Exercise / Conversion Period | Physical or cash settlement | Number of shares and voting rights | % of shares and voting rights |
Securities Lent | N/A | N/A | Physical | 43,988 shares Below 5% voting rights | 0.03% shares Below 5% voting rights |
POINT B SUBTOTAL | 43,988 shares Below 5% voting rights | 0.03% shares Below 5% voting rights |
Orion Corporation
Liisa Hurme President and CEO | Olli Huotari EVP, Corporate Functions |
Contact person:
Tuukka Hirvonen, Investor Relations
tel. +358 10 426 2721
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orionpharma.com
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Fynske Bank A/S4.7.2025 19:50:00 CEST | Pressemeddelelse
Fynske Bank og Nordfyns Bank indgår ny aftale om fusion med forhøjet fusionsvederlag
Nordfyns Bank A/S4.7.2025 19:50:00 CEST | Pressemeddelelse
Fynske Bank og Nordfyns Bank indgår ny aftale om fusion med forhøjet fusionsvederlag
Schweiter Technologies4.7.2025 18:00:00 CEST | Press release
INVITATION TO THE MEDIA & ANALYST WEBCAST
Siili Solutions Oyj4.7.2025 17:30:00 CEST | Press release
Siili Solutions Plc: Share Repurchase 4.7.2025
Tryg A/S4.7.2025 16:23:51 CEST | Press release
Correction: Consensus estimates on Tryg A/S
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom